Serotype Distribution and Antibiotic Susceptibility of
MDR
PCV
Streptococcus pneumoniae
antibiotic susceptibility
multi-drug resistance
pneumococcal conjugate vaccine
serotype
Journal
Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216
Informations de publication
Date de publication:
2020
2020
Historique:
received:
13
10
2019
accepted:
23
01
2020
entrez:
27
2
2020
pubmed:
27
2
2020
medline:
27
2
2020
Statut:
epublish
Résumé
Encapsulated A total of 80 The most common serotypes were 23F (17.5%), 14 (16.3%), 3 (16.3%) 19F (12.5%), and 19A (12.5%) in the present study. The vaccine coverage rates of PCV-7, PCV-10 and PCV-13 were 52.6%, 52.6%, and 83.7%, respectively. The results showed that majority of the circulating serotypes in our study are related to PCV-13 serotypes. The use of conjugate vaccine in the immunization program and surveillance of antimicrobial resistance can be effective in reducing the pneumococcal clinical burden.
Identifiants
pubmed: 32099424
doi: 10.2147/IDR.S234295
pii: 234295
pmc: PMC7007777
doi:
Types de publication
Journal Article
Langues
eng
Pagination
333-340Informations de copyright
© 2020 Habibi Ghahfarokhi et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Infect Chemother. 2018 Dec;50(4):328-339
pubmed: 30600656
Vaccine. 2016 Sep 14;34(40):4771-6
pubmed: 27546875
BMC Res Notes. 2017 Jan 4;10(1):21
pubmed: 28057059
PLoS One. 2017 Dec 13;12(12):e0189163
pubmed: 29236737
J Glob Antimicrob Resist. 2018 Sep;14:23-28
pubmed: 29274470
PLoS Med. 2010 Oct 05;7(10):
pubmed: 20957191
J Med Microbiol. 2017 Jul;66(7):847-858
pubmed: 28650313
J Microbiol Methods. 2015 Jun;113:41-9
pubmed: 25819558
Germs. 2017 Jun 1;7(2):78-85
pubmed: 28626738
J Glob Antimicrob Resist. 2018 Dec;15:6-11
pubmed: 29803821
Vaccine. 2018 Mar 14;36(12):1614-1620
pubmed: 29439865
Antimicrob Agents Chemother. 2012 Mar;56(3):1418-26
pubmed: 22232285
PLoS One. 2016 Dec 29;11(12):e0167803
pubmed: 28033345
Clin Infect Dis. 2009 Mar 1;48 Suppl 2:S123-8
pubmed: 19191607
Int J Infect Dis. 2017 Apr;57:21-26
pubmed: 28131730
Sci Rep. 2017 Aug 15;7(1):8127
pubmed: 28811633
PLoS One. 2018 Nov 29;13(11):e0208211
pubmed: 30496296
BMC Infect Dis. 2017 Aug 25;17(1):590
pubmed: 28841854
Microb Drug Resist. 2019 Jan/Feb;25(1):39-46
pubmed: 30070961
Medicine (Baltimore). 2019 Jun;98(24):e15942
pubmed: 31192930
Lancet Glob Health. 2018 Jul;6(7):e744-e757
pubmed: 29903376
Vaccines (Basel). 2016 Feb 22;4(1):
pubmed: 26907356
Nat Rev Microbiol. 2018 Jun;16(6):355-367
pubmed: 29599457
Epidemiology. 2017 Jan;28(1):119-126
pubmed: 27541841
J Immunol Res. 2015;2015:591580
pubmed: 26351648
PLoS One. 2012;7(12):e50406
pubmed: 23226519
Lancet Infect Dis. 2017 Mar;17(3):305-312
pubmed: 27956163
Curr Microbiol. 2015 Feb;70(2):206-11
pubmed: 25274412
Biomed Res Int. 2016;2016:6950482
pubmed: 27314035
Ann Lab Med. 2015 Jan;35(1):57-61
pubmed: 25553281
Emerg Infect Dis. 2008 Feb;14(2):275-81
pubmed: 18258121